Development of pH-responsive gelatin/PVP nanogel by gamma radiation for controlled delivery of silibinin

Résumé

Silibinin (SB) is a natural polyphenolic flavonoid with recognized health and therapeutic potential. SB has poor aqueous solubility, which limits its bioavailability and therapeutic effectiveness. To overcome these limitations, a pH-responsive gelatin/polyvinylpyrrolidone (Gel/PVP) nanogel was synthesized via γ-irradiation (5 kGy) for controlled SB delivery. SB/PVP solid dispersions were first prepared by solvent evaporation to enhance dissolution, then incorporated into the preformed Gel/PVP nanogel in the presence of N-hydroxysuccinimide (NHS), yielding the SB/Gel/PVP formulation. FTIR confirmed effective crosslinking between gelatin and PVP and successful SB encapsulation, while XRD revealed an amorphous state favorable for solubility. TEM micrograph of SB/Gel/PVP showed cubic nanoparticles < 50 nm, with a zero-point charge at pH 5.5. The nanogel achieved SB entrapment efficiency of 82% and a loading capacity of 3.34%. In vitro release studies demonstrated pH-responsive behavior, with SB release threefold higher than free drug after 6 h, and the highest release was observed at pH 4.5. The MTT assay confirmed that the SB/Gel/PVP nanogel significantly inhibited HepG2 cell proliferation compared with free SB (P < 0.05). Moreover, the biochemical and histopathological analyses of liver and kidney tissues in rats treated with SB or SB/Gel/PVP (25 mg/kg) indicated good biocompatibility. Collectively, these findings highlight Gel/PVP nanogels as a promising platform for sustained and targeted SB delivery in pharmaceutical applications.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0